NCT02651077View on ClinicalTrials.gov

Endometriosis and Brominated Flame Retardant (ENDOTOX Study)

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Endometriosis
Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
collaborator

ONIRIS

INDUSTRY

lead

Nantes University Hospital

OTHER

NCT02651077 - Endometriosis and Brominated Flame Retardant (ENDOTOX Study) | Biotech Hunter | Biotech Hunter